Matisse Capital’s CVS Health CVS Stock Holding History

Matisse Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$309K	Buy	+2,990	New	+$267K	0.12%	132
2024 Q3	–	Sell	-8,391	Closed	-$496K	–	182
2024 Q2	$496K	Hold	8,391	–	–	0.25%	116
2024 Q1	$669K	Hold	8,391	–	–	0.32%	96
2023 Q4	$663K	Hold	8,391	–	–	0.35%	97
2023 Q3	$586K	Hold	8,391	–	–	0.41%	92
2023 Q2	$580K	Hold	8,391	–	–	0.36%	99
2023 Q1	$624K	Buy	+8,391	New	+$704K	0.4%	90
2019 Q1	–	Sell	-4,727	Closed	-$310K	–	101
2018 Q4	$310K	Buy	+4,727	New	+$353K	0.39%	62

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Matisse Capital's CVS Position: Q2 2026 in Review

Matisse Capital opened a new position in CVS Health (CVS) in Q2 2026: 2,990 shares worth $309K. The stake represents 0.12% of the portfolio and ranks #132 among its holdings. This is a return to the name: Matisse Capital previously reported a position in CVS as recently as Q2 2024.

Matisse Capital first reported a position in CVS in Q4 2018 and has held it in 8 quarters since. The position peaked at $669K in Q1 2024. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Matisse Capital held 2,990 shares of CVS Health worth $309K as of Q2 2026.
CVS Health was a new Matisse Capital position in Q2 2026.
CVS Health made up 0.12% of Matisse Capital's portfolio in Q2 2026, its #132 holding.
Matisse Capital first reported a position in CVS Health in Q4 2018 and has held it in 8 quarters since.
Matisse Capital's CVS Health position peaked at $669K in Q1 2024.
2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Matisse Capital's 13F filing for Q2 2026, filed 12 Aug 2026.